Encapsulation of Strontium Ranelate in Poly(Lactic Acid) Matrix

2016 ◽  
Vol 721 ◽  
pp. 208-212 ◽  
Author(s):  
Anastasija Smirnova ◽  
Dagnija Loca ◽  
Liga Stipniece ◽  
Janis Locs ◽  
Agnese Pura

Osteoporosis is a disease characterized with reduced density and quality of bone. Novel treatment strategies have been developed with the aim to inhibit excessive bone resorption and to increase bone formation. Strontium ranelate (SrRan), a novel orally active agent consisting of two atoms of stable strontium and the organic moiety ranelic acid, has proven drug ability to increase not only the bone mass but also mechanical properties. Despite the advantages it has been shown that systemic administration of SrRan can cause such side effects as diarrhea, hypersensitivity and myocardial infarction. Microencapsulation of SrRan could overcome the possible side effects from the systemic drug use as well as to increase its efficiency by local delivery of drug right to the affected bone site. Thus in the current research an attempt was made to prepare and characterize poly (lactic acid)/srontium ranelate microcapsules and to evaluate the drug interaction with the polymer during the microparticle formation.

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 16529-16529
Author(s):  
W. C. Dempke ◽  
B. Gunawardena ◽  
B. Hesselt ◽  
R. Linke ◽  
K. A. Alimi

16529 Background: The clinical outcome of refractory head and neck cancer patients remains poor despite novel treatment strategies. In this pilot study we investigated the efficacy of intratumoral injection of 32-P chromic phosphate in 14 patients with refractory head and neck cancers in terms of response rates and overall survival. Methods: Fourteen patients (median age: 59 years) with either cytostatic drug-resistant tumors or tumors known to be primarily chemotherapy-resistant were entered into the study. After sonographic determination of the tumor volume, 32-P chromic phosphate (74–555 MBq) was injected into the central part of the tumor under sonographic guidance. Follow-up investigations included serial scintigraphy, sonographic examinations, and hematologic studies. Results: Injection of 32-P chromic phosphate into refractory head and neck tumors resulted in remarkable regression. The median survival of all patients was 7.8 months (range: 4–16). The response rate (partial response) was 57% (8 patients). However, 6 patients (43%) did not respond to the treatment. In 3 patients thrombocytopenia (grade I/II) was observed, but no other side effects were apparent. Significant pathologic and anatomic changes within the tumor tissue were demonstrated. In all cases examined, formation of a cyst within the area of central activity, surrounded by a centrifugal necrotic ring and a marginal fibrotic structure, was found. Conclusions: Lack of persistent systemic or local side effects, as well as noteworthy efficacy, are properties of this novel regional treatment modality with 32-P chromic phosphate. This modality deserves consideration for further clinical trials. No significant financial relationships to disclose.


2011 ◽  
Vol 131 (5) ◽  
pp. 395-400 ◽  
Author(s):  
Toru Oi ◽  
Katsuyoshi Shinyama ◽  
Shigetaka Fujita

2014 ◽  
Vol 134 (4) ◽  
pp. 237-242
Author(s):  
Naru Matsugasaki ◽  
Katsuyoshi Shinyama ◽  
Shigetaka Fujita

2019 ◽  
Vol 21 (10) ◽  
pp. 734-748 ◽  
Author(s):  
Baoling Guo ◽  
Qiuxiang Zheng

Aim and Objective: Lung cancer is a highly heterogeneous cancer, due to the significant differences in molecular levels, resulting in different clinical manifestations of lung cancer patients there is a big difference. Including disease characterization, drug response, the risk of recurrence, survival, etc. Method: Clinical patients with lung cancer do not have yet particularly effective treatment options, while patients with lung cancer resistance not only delayed the treatment cycle but also caused strong side effects. Therefore, if we can sum up the abnormalities of functional level from the molecular level, we can scientifically and effectively evaluate the patients' sensitivity to treatment and make the personalized treatment strategies to avoid the side effects caused by over-treatment and improve the prognosis. Result & Conclusion: According to the different sensitivities of lung cancer patients to drug response, this study screened out genes that were significantly associated with drug resistance. The bayes model was used to assess patient resistance.


2019 ◽  
Vol 19 (7) ◽  
pp. 913-920
Author(s):  
Fabiani L. R. Beal ◽  
Pedro R. Beal ◽  
Juliana R. Beal ◽  
Natan Carvalho-Neves ◽  
Octávio L. Franco ◽  
...  

Background: Arginine is considered a semi-essential amino acid in healthy adults and the elderly. This amino acid seems to improve the immune system, stimulate cell growth and differentiation, and increase endothelial permeability, among other effects. For those reasons, it has been theorized that arginine supplementation may be used as an adjuvant to conventional cancer therapy treatments. Objective: This review aims to evaluate the existing knowledge of the scientific community on arginine supplementation in order to improve the efficacy of current cancer treatment. Results: Despite the continued efforts of science to improve treatment strategies, cancer remains one of the greatest causes of death on the planet in adults and elderly people. Chemo and radiotherapy are still the most effective treatments but at the cost of significant side effects. Conclusion: Thus, new therapeutic perspectives have been studied in recent years, to be used in addition to traditional treatments or not, seeking to treat or even cure the various types of cancer with fewer side effects.


2020 ◽  
Vol 62 (6) ◽  
pp. 732-743
Author(s):  
Chi-Hui Tsou ◽  
Jipeng Guo ◽  
Ji-Ang Lei ◽  
Manuel Reyes De Guzman ◽  
Maw-Cherng Suen
Keyword(s):  

2019 ◽  
Vol 821 ◽  
pp. 89-95
Author(s):  
Wanasorn Somphol ◽  
Thipjak Na Lampang ◽  
Paweena Prapainainar ◽  
Pongdhorn Sae-Oui ◽  
Surapich Loykulnant ◽  
...  

Poly (lactic acid) or PLA was reinforced by nanocellulose and polyethylene glycol (PEG), which were introduced into PLA matrix from 0 to 3 wt.% to enhance compatibility and strength of the PLA. The nanocellulose was prepared by TEMPO-mediated oxidation from microcrystalline cellulose (MCC) powder and characterized by TEM, AFM, and XRD to reveal rod-like shaped nanocellulose with nanosized dimensions, high aspect ratio and high crystallinity. Films of nanocellulose/PEG/PLA nanocomposites were prepared by solvent casting method to evaluate the mechanical performance. It was found that the addition of PEG in nanocellulose-containing PLA films resulted in an increase in tensile modulus with only 1 wt% of PEG, where higher PEG concentrations negatively impacted the tensile strength. Furthermore, the tensile strength and modulus of nanocellulose/PEG/PLA nanocomposites were higher than the PLA/PEG composites due to the existence of nanocellulose chains. Visual traces of crazing were detailed to describe the deformation mechanism.


Sign in / Sign up

Export Citation Format

Share Document